Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality
Authors
Keywords
Breast cancer, Adjuvant treatments, Neoadjuvant treatments, Treatment benefits, Treatment harms
Journal
CANCER TREATMENT REVIEWS
Volume 105, Issue -, Pages 102375
Publisher
Elsevier BV
Online
2022-03-04
DOI
10.1016/j.ctrv.2022.102375
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abstract GS2-06: Taxane with anthracycline versus taxane without anthracycline: An individual patient-level meta-analysis of 16,500 women with early-stage breast cancer in 13 randomised trials
- (2022) Jeremy Braybrooke et al. CANCER RESEARCH
- Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
- (2021) Larissa A. Korde et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up
- (2021) Martine Piccart et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials
- (2021) Rosie Bradley et al. LANCET ONCOLOGY
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
- (2021) H.J. Burstein et al. ANNALS OF ONCOLOGY
- A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer
- (2021) Amy Zhao et al. BREAST
- Abemaciclib With Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation Update
- (2021) Sharon H. Giordano et al. JOURNAL OF CLINICAL ONCOLOGY
- Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010–2020
- (2021) Frances K. Duane et al. RADIOTHERAPY AND ONCOLOGY
- Dose-volume effects of breast cancer radiation therapy on the risk of second oesophageal cancer
- (2020) Neige Journy et al. RADIOTHERAPY AND ONCOLOGY
- Internal mammary and medial supraclavicular lymph node chain irradiation in stage I–III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial
- (2020) Philip M Poortmans et al. LANCET ONCOLOGY
- Communicating prognosis to women with early breast cancer – overview of prediction tools and the development and pilot testing of a decision aid
- (2019) Viktoria Mühlbauer et al. BMC HEALTH SERVICES RESEARCH
- Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2019) F Cardoso et al. ANNALS OF ONCOLOGY
- Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019
- (2019) H J Burstein et al. ANNALS OF ONCOLOGY
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial
- (2019) Frank A Vicini et al. LANCET
- Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis
- (2018) F Poggio et al. ANNALS OF ONCOLOGY
- A Systematic Review of Heart Dose in Breast Radiotherapy
- (2018) Leah Drost et al. Clinical Breast Cancer
- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update
- (2018) Neelima Denduluri et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
- (2018) Bernard Asselain et al. LANCET ONCOLOGY
- Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2018) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
- (2018) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2018) Eleftherios P Mamounas et al. LANCET ONCOLOGY
- Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
- (2018) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials
- (2017) Carolyn Taylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Sukhbinder Dhesy-Thind et al. JOURNAL OF CLINICAL ONCOLOGY
- Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Miguel Martin et al. LANCET ONCOLOGY
- Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials
- (2017) Ezzeldin M. Ibrahim et al. MEDICAL ONCOLOGY
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
- (2017) Norikazu Masuda et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of decision aids for patients making a decision about treatment for early breast cancer
- (2016) Nicholas Zdenkowski et al. BREAST
- Can Observational Data Replace Randomized Trials?
- (2016) Paul McGale et al. JOURNAL OF CLINICAL ONCOLOGY
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
- (2016) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exposure of the Heart in Breast Cancer Radiation Therapy: A Systematic Review of Heart Doses Published During 2003 to 2013
- (2015) Carolyn W. Taylor et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
- (2015) LANCET
- Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
- (2015) Harry Bartelink et al. LANCET ONCOLOGY
- Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials
- (2014) EBCTCG (Early Breast Cancer Trialists' Collaborative Group) LANCET
- A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
- (2014) M. A. Puhan et al. BMJ-British Medical Journal
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
- (2013) Sarah C. Darby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17
- (2008) J. N. Ingle et al. ANNALS OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now